KOL Lunch on the Future of Precision Medicine, hosted by HTG Molecular (HTGM)

The event will feature a presentation by Laura E. Benjamin, Ph.D. (Founder and CEO, Oncologie, LTD) who will discuss the future of precision medicine and its potential to bring innovative new medicines to cancer patients globally.